Cytogenetic characteristics among 1580 patients with adequate karyotypes
Cytogenetic classification . | Whites, n (%) . | African Americans, n (%) . | Total, n (%) . |
|---|---|---|---|
| t(15;17)* | 66 (4.7) | 14 (8.3) | 80 (5.1) |
| t(9;22)* | 6 (0.4) | 3 (1.8) | 9 (0.6) |
| Not included in risk group | 98 (7) | 10 (6) | 108 (6.8) |
| Included in risk group | 1242 (88.0) | 141 (83.9) | 1383 (87.5) |
| Total | 1412 (100) | 168 (100) | 1580 (100) |
| Risk group† | |||
| Favorable | 173 (14) | 32 (23) | 205 (15) |
| Intermediate | 786 (63) | 66 (47) | 852 (62) |
| Unfavorable | 283 (23) | 43 (31) | 326 (24) |
| Total | 1242 (100) | 141 (100) | 1383 (100) |
Cytogenetic classification . | Whites, n (%) . | African Americans, n (%) . | Total, n (%) . |
|---|---|---|---|
| t(15;17)* | 66 (4.7) | 14 (8.3) | 80 (5.1) |
| t(9;22)* | 6 (0.4) | 3 (1.8) | 9 (0.6) |
| Not included in risk group | 98 (7) | 10 (6) | 108 (6.8) |
| Included in risk group | 1242 (88.0) | 141 (83.9) | 1383 (87.5) |
| Total | 1412 (100) | 168 (100) | 1580 (100) |
| Risk group† | |||
| Favorable | 173 (14) | 32 (23) | 205 (15) |
| Intermediate | 786 (63) | 66 (47) | 852 (62) |
| Unfavorable | 283 (23) | 43 (31) | 326 (24) |
| Total | 1242 (100) | 141 (100) | 1383 (100) |